Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2013
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2013
Report date:
2013

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
other: EU Method B.46 (Skin Irritation)
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany

Test material

Constituent 1
Chemical structure
Reference substance name:
(6E)-N-[(2R,3S,4S,5S)-6-hydroxy-2,3,4,5-tetramethylhexyl]-N-methyloctadec-6-enamide; N-[(2R,3S,4S,5S)-6-hydroxy-2,3,4,5-tetramethylhexyl]-N-methyloctadecanamide
EC Number:
940-373-5
Cas Number:
1591782-99-8
Molecular formula:
C25H49NO6 (C18 unsatd.) C25H51NO6 (C18 satd.)
IUPAC Name:
(6E)-N-[(2R,3S,4S,5S)-6-hydroxy-2,3,4,5-tetramethylhexyl]-N-methyloctadec-6-enamide; N-[(2R,3S,4S,5S)-6-hydroxy-2,3,4,5-tetramethylhexyl]-N-methyloctadecanamide
Test material form:
other: Waxy solid

Test system

Amount / concentration applied:
Solids: 10 mg + 5 µL aqua dest.]
Duration of treatment / exposure:
15 minutes
Observation period:
42 +/- 1 h
Details on study design:
The test was performed on EpiSkin, an organotypic reconstructed three-dimensional model of the human epidermis. 3 replicate tissues are dosed with the test item, the negative control (10µL PBS) and the positive control (10µL 5% SDS), respectively. After 15 minutes treatment period at room temperature the test item and the controls are rinsed off with PBS and the tissues are post-incubated for 42 +/- 1 h. Then the tissues are stained via MTT for 3 hours. Isopropanol extracts are measured photometrically at 550 nm.

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
other: other: mean relative tissue viability
Value:
>= 50
Remarks on result:
other:
Remarks:
Basis: other: mean tissue viability of negative control tissue. Time point: 15 minutes treatment followed by 42 h post-incubation. Reversibility: other: not measured in test system. Remarks: non-irritant, no category (EU CLP and UN GHS). (migrated information)
Irritation / corrosion parameter:
other: other: mean relative tissue viability
Value:
<= 50
Remarks on result:
other:
Remarks:
Basis: other: mean tissue viability of negative control tissue. Time point: 15 minute treatment followed by 42 hour post-incubation. Reversibility: other: not measured in test system. Remarks: irritant, category 2 (EU CLP and UN GHS). (migrated information)

In vivo

Other effects:
The test item showed no direct MTT reducing capability and no colouring potential.

Applicant's summary and conclusion

Interpretation of results:
not irritating
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The test item is classified as "non-irritant" (No Category).
Executive summary:

The skin irritant potential of the test substance (active content 80.4%) was investigated using the EPISKIN-Standard Model (EPISKIN-SMTM), a reconstituted three-dimensional human epidermis model as a replacement for the Draize Skin Irritation Test (OECD 404). The test compound was applied topically to the EPISKIN-SM tissue [10 mg test item + 5 µL A. dest.] for 15 minutes followed by a 42 hour post incubation period and immediate determination of cytotoxic effects via MTT reduction assay. Irritant potential was predicted from the relative mean tissue viabilities obtained compared to the corresponding negative control tissues concurrently treated with PBS. The test item showed no irritant effects. The mean relative tissue viability (% negative control) was >50% after 15 minutes treatment and 42 hour post incubation. The controls confirmed the validity of the study. C18/18 unsatd.-Glucamide therefore classified as non-irritant in accordance with UN GHS and EU CLP "No Category".